PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Dec-2024 Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025 AccessWire
24-Dec-2024 Strong Natural Diet Pill Over the Counter for 2025 - PhenQ OTC Weight Loss Supplement AccessWire
24-Dec-2024 MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV AccessWire
24-Dec-2024 Mexico's EHR Revolution: Driving Digital Health Innovation and Market Growth, Insights From Black Book Research AccessWire
24-Dec-2024 AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd. AccessWire
23-Dec-2024 Abivax Announces a Change to the Composition of its Board of Directors ABIVAX
23-Dec-2024 Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI GmbH by Pineapple Power Corporation PLC at an Expected Valuation of EUR 80-90 million Xlife Sciences AG
23-Dec-2024 Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025 AccessWire
23-Dec-2024 Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease Newswire
23-Dec-2024 Hochul Signs Step Therapy Reform Measures Into Law AccessWire
23-Dec-2024 China's Digital Healthcare Transformation: Local Vendors Lead 2025 EHR Adoption, Highlights Black Book Research AccessWire
23-Dec-2024 Open Healthcare Inc. Expands U.S. Operations With CTON Laboratory Acquisition, New Facility in Gardena, and Appointment of New COO AccessWire
23-Dec-2024 Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000 AccessWire
23-Dec-2024 Honeycomb Clinic Positions for Public Offering AccessWire
23-Dec-2024 Ensysce Biosciences Regains Full Compliance with Nasdaq AccessWire
23-Dec-2024 Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease AccessWire
23-Dec-2024 NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape AccessWire
23-Dec-2024 Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone AccessWire
23-Dec-2024 Siegfried once again confirmed in the Dow Jones Sustainability Index Europe Siegfried AG
20-Dec-2024 Quantum Biopharma Announces Closing of Second Tranche AccessWire